LENNON DAVID JAMES (CHIEF EXECUTIVE OFFICER) sold 10.3% of their position (5.10K shares) of WHITEHAWK THERAPEUTICS, INC. on the open market
Open‑market sale worth $16.9K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/10/2026ACC: 0001995275-26-000002
DirectorOfficer· CHIEF EXECUTIVE OFFICER
Since Mar 2026
-5.10K
Net shares
Net seller
$16.9K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
16.25K acquired · 21.35K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+16.25K
Price / share
—
Trade value
—
% of position
48.6%
3/1/2026
33.43K→49.68K
Common Stock
Direct
Shares
−5.10K
Price / share
$3.31
Trade value
$16.88K
% of position
10.3%
3/2/2026
49.68K→44.58K
Total
Net shares
+11.15K
Net value
-$16.88K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/1/2026 | M · Option Exercise | +16.25K | — | — | 48.6% | 33.43K | 49.68K |
| Common Stock Direct | 3/2/2026 | S · Sale | −5.10K | $3.31 | $16.88K | 10.3% | 49.68K | 44.58K |
| Total | +11.15K | -$16.88K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
16.25K shares
Shares
−16.25K
Strike price
Held after
32.50K
Exercisable
—
3/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock16.25K shares | 3/1/2026 | M · Option Exercise | −16.25K | — | 32.50K |